Lisanti Capital Growth, LLC reported 95 positions worth $372.86M for the quarter ended Sep 30, 2026, down 18.0% on the prior quarter. It opened 52 new positions, added to 13, trimmed 29 and exited 66. Its largest holding is Corcept Therapeutics Inc at 2.8% of the portfolio.
Reported 13F market value at each quarter end. A change mixes trading with price moves in the positions held.
Dollar value of shares bought and sold each quarter, at that quarter’s price. It counts trading only, not price changes.
How many positions were opened, added to, trimmed or closed each quarter.
Share of reported value in each sector at every quarter end.
| Holding | Change | Change % | Trade Value | Weight |
|---|---|---|---|---|
| CDNA CareDx, Inc. | +130.2K | – | $8.46M | 2.27% |
| GKOS GLAUKOS Corp | +44.1K | – | $7.24M | 1.94% |
| ELF e.l.f. Beauty, Inc. | +64.0K | – | $6.46M | 1.73% |
| BMRN Biomarin Pharmaceutical Inc | +102.9K | – | $6.18M | 1.66% |
| TWST Twist Bioscience Corp | +28.9K | – | $5.58M | 1.5% |
| CHEF Chefs' Warehouse, Inc. | +46.0K | – | $5.16M | 1.38% |
| QTWO Q2 Holdings, Inc. | +89.8K | – | $4.98M | 1.34% |
| NTSK Netskope Inc | +271.8K | – | $4.74M | 1.27% |
| PI Impinj Inc | +25.9K | +462.0% | $4.63M | 1.51% |
| AXTI Axt Inc | +58.7K | – | $4.54M | 1.22% |
| Holding | Change | Change % | Trade Value | Weight |
|---|---|---|---|---|
| BTSG BrightSpring Health Services, Inc. | -154.6K | -100.0% | $10.78M | Exited |
| ALGM Allegro Microsystems, Inc. | -107.9K | -100.0% | $7.51M | Exited |
| MIRM Mirum Pharmaceuticals, Inc. | -63.3K | -100.0% | $7.41M | Exited |
| CRS Carpenter Technology Corp | -11.7K | -100.0% | $7.20M | Exited |
| DY Dycom Industries Inc | -14.2K | -100.0% | $7.16M | Exited |
| CVLT Commvault Systems Inc | -49.6K | -100.0% | $7.04M | Exited |
| ENVA Enova International, Inc. | -27.7K | -100.0% | $6.66M | Exited |
| CROX Crocs, Inc. | -52.8K | -100.0% | $6.37M | Exited |
| EXTR Extreme Networks Inc | -183.1K | -100.0% | $5.93M | Exited |
| VCEL Vericel Corp | -120.4K | -100.0% | $5.36M | Exited |
| Holding | Shares | Trade Value | Weight |
|---|---|---|---|
| CDNA CareDx, Inc. | +130.2K | $8.46M | 2.27% |
| GKOS GLAUKOS Corp | +44.1K | $7.24M | 1.94% |
| ELF e.l.f. Beauty, Inc. | +64.0K | $6.46M | 1.73% |
| BMRN Biomarin Pharmaceutical Inc | +102.9K | $6.18M | 1.66% |
| TWST Twist Bioscience Corp | +28.9K | $5.58M | 1.5% |
| CHEF Chefs' Warehouse, Inc. | +46.0K | $5.16M | 1.38% |
| QTWO Q2 Holdings, Inc. | +89.8K | $4.98M | 1.34% |
| NTSK Netskope Inc | +271.8K | $4.74M | 1.27% |
| AXTI Axt Inc | +58.7K | $4.54M | 1.22% |
| FIVE Five Below, Inc | +20.5K | $4.49M | 1.21% |
| Holding | Shares Sold | Trade Value | Prior Weight |
|---|---|---|---|
| BTSG BrightSpring Health Services, Inc. | -154.6K | $10.78M | 2.37% |
| ALGM Allegro Microsystems, Inc. | -107.9K | $7.51M | 1.65% |
| MIRM Mirum Pharmaceuticals, Inc. | -63.3K | $7.41M | 1.63% |
| CRS Carpenter Technology Corp | -11.7K | $7.20M | 1.58% |
| DY Dycom Industries Inc | -14.2K | $7.16M | 1.58% |
| CVLT Commvault Systems Inc | -49.6K | $7.04M | 1.55% |
| ENVA Enova International, Inc. | -27.7K | $6.66M | 1.46% |
| CROX Crocs, Inc. | -52.8K | $6.37M | 1.4% |
| EXTR Extreme Networks Inc | -183.1K | $5.93M | 1.3% |
| VCEL Vericel Corp | -120.4K | $5.36M | 1.18% |
| # | Activity | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | CORT Corcept Therapeutics Inc | Healthcare | 89.4K | $10.30M | 2.76% | -2,260 | -2.5% | Reduced | 0.08% |
| 2 | HNGE Hinge Health, Inc. | Healthcare | 101.7K | $9.89M | 2.65% | -37.5K | -26.9% | Reduced | 0.16% |
| 3 | KNSA Kiniksa Pharmaceuticals International, plc | Healthcare | 129.3K | $9.64M | 2.59% | +41.9K | +48.0% | Added | 0.17% |
| 4 | MGNI Magnite, Inc. | Technology | 361.0K | $9.12M | 2.45% | +72.0K | +24.9% | Added | 0.25% |
| 5 | CDNA CareDx, Inc. | Healthcare | 130.2K | $8.46M | 2.27% | +130.2K | – | New | 0.25% |
| 6 | HTFL Heartflow, Inc. | Healthcare | 155.3K | $7.73M | 2.07% | -34.4K | -18.1% | Reduced | 0.18% |
| 7 | ZETA Zeta Global Holdings Corp. | Technology | 244.5K | $7.72M | 2.07% | -106.9K | -30.4% | Reduced | 0.11% |
| 8 | GKOS GLAUKOS Corp | Healthcare | 44.1K | $7.24M | 1.94% | +44.1K | – | New | 0.07% |
| 9 | FIVN Five9, Inc. | Technology | 201.1K | $6.84M | 1.83% | +7,430 | +3.8% | Added | 0.27% |
| 10 | ELF e.l.f. Beauty, Inc. | Consumer Staples | 64.0K | $6.46M | 1.73% | +64.0K | – | New | 0.11% |
| 11 | XMTR Xometry, Inc. | Technology | 61.0K | $6.27M | 1.68% | -39.9K | -39.6% | Reduced | 0.11% |
| 12 | BMRN Biomarin Pharmaceutical Inc | Healthcare | 102.9K | $6.18M | 1.66% | +102.9K | – | New | 0.05% |
| 13 | ALNT Allient Inc | Industrials | 55.2K | $6.16M | 1.65% | +24.3K | +78.6% | Added | 0.32% |
| 14 | ADPT Adaptive Biotechnologies Corp | Healthcare | 211.6K | $6.12M | 1.64% | -113.5K | -34.9% | Reduced | 0.13% |
| 15 | GRDN Guardian Pharmacy Services, Inc. | Healthcare | 147.4K | $6.01M | 1.61% | -4,590 | -3.0% | Reduced | 0.23% |
Tip. Select a row to see that position’s full history at Lisanti Capital Growth.
As of its Q3 2026 13F filing, Lisanti Capital Growth, LLC’s five largest positions were Corcept Therapeutics Inc (CORT) at 2.8%, Hinge Health, Inc. (HNGE) at 2.7%, Kiniksa Pharmaceuticals International, plc (KNSA) at 2.6%, Magnite, Inc. (MGNI) at 2.4%, CareDx, Inc. (CDNA) at 2.3% of the reported portfolio.
Lisanti Capital Growth, LLC reported a 13F portfolio worth $372.86M across 95 positions for Q3 2026. That is down 18.0% from the previous quarter.
Its largest purchases by value were CareDx, Inc. ($8.46M), GLAUKOS Corp ($7.24M), e.l.f. Beauty, Inc. ($6.46M). It opened 52 new positions.
Its largest sales by value were BrightSpring Health Services, Inc. ($10.78M), Allegro Microsystems, Inc. ($7.51M), Mirum Pharmaceuticals, Inc. ($7.41M). It exited 66 positions entirely.
From the Form 13F-HR reports Lisanti Capital Growth, LLC files with the SEC each quarter, within 45 days of quarter end. A 13F lists long positions in US-listed equities and options; it excludes short positions, cash, bonds and most non-US holdings.
13F data reflects long positions in US-listed equities and options as reported to the SEC up to 45 days after quarter end. It excludes short positions, cash, bonds and most non-US securities, so it is not a complete picture of a manager’s assets.